Sarah James
Stock Analyst at Cantor Fitzgerald
(1.98)
# 3,106
Out of 5,148 analysts
306
Total ratings
34.8%
Success rate
-7.04%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Maintains: Neutral | $250 → $229 | $206.42 | +10.94% | 28 | Feb 27, 2026 | |
| MDXG MiMedx Group | Maintains: Overweight | $12 → $8 | $4.88 | +63.93% | 1 | Feb 17, 2026 | |
| HUM Humana | Maintains: Neutral | $290 → $201 | $187.28 | +7.33% | 22 | Feb 12, 2026 | |
| MOH Molina Healthcare | Maintains: Neutral | $180 → $144 | $152.42 | -5.52% | 15 | Feb 9, 2026 | |
| CNC Centene | Reiterates: Neutral | $41 | $44.60 | -8.07% | 17 | Feb 9, 2026 | |
| HCA HCA Healthcare | Maintains: Overweight | $525 → $588 | $532.92 | +10.34% | 22 | Jan 28, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Neutral | $22 → $17 | $23.44 | -27.47% | 18 | Dec 3, 2025 | |
| CVS CVS Health | Maintains: Overweight | $78 → $95 | $81.66 | +16.34% | 16 | Oct 30, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $190 → $245 | $235.12 | +4.20% | 23 | Oct 29, 2025 | |
| SGRY Surgery Partners | Reiterates: Overweight | $36 | $15.88 | +126.70% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $1.68 | +138.10% | 8 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $440 | $294.93 | +49.19% | 18 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $290.85 | +25.49% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $28 | $17.60 | +59.09% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $485 | $294.07 | +64.93% | 20 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $29 | $19.07 | +52.07% | 6 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $2.91 | +415.46% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $0.69 | +624.64% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $5.16 | +93.80% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $153.98 | -13.63% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $22.81 | +84.13% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $9.27 | -46.06% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $7.43 | -32.71% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $19.65 | +6.87% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $75.22 | -48.15% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $81.37 | +137.19% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.39 | - | 2 | Mar 1, 2017 |
Universal Health Services
Feb 27, 2026
Maintains: Neutral
Price Target: $250 → $229
Current: $206.42
Upside: +10.94%
MiMedx Group
Feb 17, 2026
Maintains: Overweight
Price Target: $12 → $8
Current: $4.88
Upside: +63.93%
Humana
Feb 12, 2026
Maintains: Neutral
Price Target: $290 → $201
Current: $187.28
Upside: +7.33%
Molina Healthcare
Feb 9, 2026
Maintains: Neutral
Price Target: $180 → $144
Current: $152.42
Upside: -5.52%
Centene
Feb 9, 2026
Reiterates: Neutral
Price Target: $41
Current: $44.60
Upside: -8.07%
HCA Healthcare
Jan 28, 2026
Maintains: Overweight
Price Target: $525 → $588
Current: $532.92
Upside: +10.34%
Acadia Healthcare Company
Dec 3, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $23.44
Upside: -27.47%
CVS Health
Oct 30, 2025
Maintains: Overweight
Price Target: $78 → $95
Current: $81.66
Upside: +16.34%
Tenet Healthcare
Oct 29, 2025
Maintains: Overweight
Price Target: $190 → $245
Current: $235.12
Upside: +4.20%
Surgery Partners
Oct 7, 2025
Reiterates: Overweight
Price Target: $36
Current: $15.88
Upside: +126.70%
Oct 7, 2025
Reiterates: Neutral
Price Target: $4
Current: $1.68
Upside: +138.10%
Aug 26, 2025
Reiterates: Overweight
Price Target: $440
Current: $294.93
Upside: +49.19%
Aug 26, 2025
Reiterates: Overweight
Price Target: $365
Current: $290.85
Upside: +25.49%
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $17.60
Upside: +59.09%
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $294.07
Upside: +64.93%
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $19.07
Upside: +52.07%
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $2.91
Upside: +415.46%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $0.69
Upside: +624.64%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $5.16
Upside: +93.80%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $153.98
Upside: -13.63%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $22.81
Upside: +84.13%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $9.27
Upside: -46.06%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $7.43
Upside: -32.71%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $19.65
Upside: +6.87%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $75.22
Upside: -48.15%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $81.37
Upside: +137.19%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.39
Upside: -